InnovAge Holding Corp
NASDAQ: INNV · HEALTHCARE · MEDICAL CARE FACILITIES
Updated 2026-09-18
InnovAge Holding Corp (INNV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.03M | $735717.00 | $4.82M | $8.82M | $465.63M | $567.19M | $637.80M | $698.64M | $688.09M | $763.86M | $853.70M | $989.71M |
| Revenue growth (YoY) | — | -28.6% | +555.0% | +83.0% | +5181.5% | +21.8% | +12.4% | +9.5% | -1.5% | +11.0% | +11.8% | +15.9% |
| Cost of revenue | $292080.00 | $340713.00 | $1.08M | $1.85M | $355.00M | $425.89M | $476.01M | $563.27M | $586.80M | $631.79M | $268.91M | $783.09M |
| Gross profit | $738033.00 | $395004.00 | $3.74M | $6.97M | $110.63M | $141.30M | $161.79M | $135.37M | $101.29M | $132.06M | $584.79M | $206.62M |
| Gross margin | 71.6% | 53.7% | 77.5% | 79.0% | 23.8% | 24.9% | 25.4% | 19.4% | 14.7% | 17.3% | 68.5% | 20.9% |
| R&D | $143914.00 | $77804.00 | $77804.00 | $38811.00 | $160000.00 | — | — | — | — | — | — | — |
| SG&A | $4.38M | $3.91M | $9.49M | $12.03M | $48.25M | $58.48M | $132.33M | $101.65M | $115.64M | $111.34M | $122.06M | $166.49M |
| Operating income | $-3.78M | $-3.52M | $-5.83M | $-5.10M | $39.67M | $50.93M | $74.82M | $-4.41M | $-49.40M | $-23.18M | $-29.76M | $66.28M |
| Operating margin | -367.4% | -477.8% | -121.1% | -57.8% | 8.5% | 9.0% | 11.7% | -0.6% | -7.2% | -3.0% | -3.5% | 6.7% |
| EBITDA | — | — | — | — | $45.92M | $61.54M | $-5.89M | $9.21M | $-33.85M | $1.15M | $3.36M | $87.42M |
| EBITDA margin | 0.0% | 0.0% | 0.0% | 0.0% | 9.9% | 10.9% | -0.9% | 1.3% | -4.9% | 0.2% | 0.4% | 8.8% |
| EBIT | $-3.78M | $-3.52M | $-6.41M | $-4.99M | $36.92M | $50.25M | $-18.18M | $-4.71M | $-49.27M | $-17.80M | $-16.15M | $66.28M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $9.59M | $14.62M | $16.79M | $2.53M | $1.52M | $4.02M | $4.61M | $4.26M |
| Income tax | $0.00 | $-757028.00 | $2400.00 | $3000.00 | $6.32M | $9.87M | $9.77M | $723000.00 | $-7.24M | $1.40M | $1.32M | — |
| Effective tax rate | 0.0% | 15.3% | -0.0% | -0.0% | 24.4% | 27.3% | -28.6% | -12.5% | 15.1% | -7.0% | -4.5% | 0.0% |
| Net income | $-4.83M | $-4.20M | $-13.70M | $-6.50M | $19.58M | $26.28M | $-43.99M | $-6.52M | $-40.67M | $-21.34M | $-30.31M | $-2.54M |
| Net income growth (YoY) | — | +12.9% | -226.0% | +52.5% | +401.0% | +34.2% | -267.4% | +85.2% | -523.7% | +47.5% | -42.1% | +91.6% |
| Profit margin | -468.6% | -571.2% | -284.3% | -73.8% | 4.2% | 4.6% | -6.9% | -0.9% | -5.9% | -2.8% | -3.6% | -0.3% |
Frequently asked questions
What is InnovAge Holding Corp's revenue?
InnovAge Holding Corp's trailing twelve-month revenue is $989.71M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is INNV?
In its most recent fiscal year, INNV ran a gross margin of 20.88%, an operating margin of 6.70%, and a net margin of -0.26%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does INNV generate?
INNV produced $50.41M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is INNV's balance sheet healthy?
INNV holds $97.89M in cash and equivalents against $45.52M in long-term debt, on $235.60M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.